Immediate Impact

58 standout
Sub-graph 1 of 22

Citing Papers

Tailoring traditional Chinese medicine in cancer therapy
2025 Standout
Patient‐derived xenograft model in cancer: establishment and applications
2025 Standout
1 intermediate paper

Works of Shengzi Wang being referenced

Efficacy and safety of Huachansu combined with adjuvant chemotherapy in resected colorectal cancer patients: a prospective, open-label, randomized phase II study
2023
Gemcitabine, dexamethasone, and cisplatin (GDP) chemotherapy with sandwiched radiotherapy in the treatment of newly diagnosed stage IE/IIE extranodal natural killer/T‐cell lymphoma, nasal type
2019

Author Peers

Author Last Decade Papers Cites
Shengzi Wang 156 134 168 27 372
Panos Goumas 85 74 92 26 358
Rina Jiromaru 190 132 189 32 337
Paolo Balercia 75 68 174 39 346
Neeraja Konuthula 68 62 131 21 337
Metka Volavšek 68 62 143 37 434
Maxime Mermod 107 180 163 21 355
Tetsuyo ODAJIMA 142 59 61 30 408
Marion Classe 112 84 147 31 403
G. Raspall 220 60 96 17 408
Jian Guo 77 21 55 23 354

All Works

Loading papers...

Rankless by CCL
2026